1.
Leukemia
; 17(2): 463-5, 2003 Feb.
Article
in English
| MEDLINE
| ID: mdl-12592349
Subject(s)
Myelodysplastic Syndromes/drug therapy , Myelodysplastic Syndromes/genetics , Philadelphia Chromosome , Piperazines/therapeutic use , Pyrimidines/therapeutic use , Aged , Antineoplastic Agents/therapeutic use , Benzamides , Bone Marrow Cells/pathology , Female , Fusion Proteins, bcr-abl/genetics , Gene Expression Regulation, Neoplastic , Granulocytes/pathology , Granulocytes/physiology , Humans , Imatinib Mesylate , RNA, Messenger/genetics , Transcription, Genetic
2.
Am J Clin Pathol
; 96(3): 434-5, 1991 Sep.
Article
in English
| MEDLINE
| ID: mdl-1831589
3.
Br J Haematol
; 79(1): 119-20, 1991 Sep.
Article
in English
| MEDLINE
| ID: mdl-1716959
4.
Br J Haematol
; 69(3): 421, 1988 Jul.
Article
in English
| MEDLINE
| ID: mdl-3136793
Subject(s)
Factor IX , Factor VIII , Hepatitis B/transmission , Child , Drug Contamination , Hot Temperature , Humans , Male , Middle Aged
5.
Lancet
; 1(8536): 763-5, 1987 Apr 04.
Article
in English
| MEDLINE
| ID: mdl-2882180
ABSTRACT
A randomised therapeutic trial of 13-cis-retinoic acid was carried out in 70 patients with myelodysplastic syndrome having 5% or fewer marrow blast cells. Among non-sideroblastic patients the 1-year survival in the treated group was 77%, compared with 36% in the control group. There were too few deaths among patients with sideroblastic anaemia to allow any effect of therapy on survival to be evaluated.
Subject(s)
Myelodysplastic Syndromes/drug therapy , Tretinoin/therapeutic use , Adult , Aged , Aged, 80 and over , Anemia, Sideroblastic/drug therapy , Anemia, Sideroblastic/mortality , Clinical Trials as Topic , Female , Humans , Isomerism , Isotretinoin , Male , Middle Aged , Myelodysplastic Syndromes/mortality , Random Allocation
6.
J Hosp Infect
; 2(4): 373-6, 1981 Dec.
Article
in English
| MEDLINE
| ID: mdl-6175695